Accelevir Diagnostics Llc
CAGE Code: 7FL22
NCAGE Code: 7FL22
Status: Active
Type: Commercial Supplier
Summary
Accelevir Diagnostics Llc is an Active Commercial Supplier with the Cage Code 7FL22.
Address
701 E Pratt St
Ste 4016
Baltimore MD 21202-3183
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Graybar Electric Company, Inc. Gvb Enterprises Reville Services Vicks Consulting Llc Safety-Kleen Corp Best Western Hotel Bobker Bearing Amilburn Co Yankee Engineering Co Inc Transunion Llc Century Autoline Metal Lubricants Merico Sales Inc Inphomation Communications Inc Morris James B Enterprise Banah Construction Crook H E Co Inc Maryland Shipbuilding And Drydock Co Alexanders Moving & Storage Eastern Broad Spectrum Optics Llc Whitehead Metals Inc
Frequently Asked Questions (FAQ) for CAGE 7FL22
- What is CAGE Code 7FL22?
- 7FL22 is the unique identifier used by NATO Organizations to reference the physical entity known as Accelevir Diagnostics Llc located at 701 E Pratt St, Ste 4016, Baltimore MD 21202-3183, United States.
- Who is CAGE Code 7FL22?
- 7FL22 refers to Accelevir Diagnostics Llc located at 701 E Pratt St, Ste 4016, Baltimore MD 21202-3183, United States.
- Where is CAGE Code 7FL22 Located?
- CAGE Code 7FL22 is located in Baltimore, MD, USA.
Contracting History for CAGE 7FL22 Most Recent 25 Records
- 75N93023C00017
- Proviral Sequencing Driven Development Of Enhanced Ipdav2 With Global Hiv-1 Group M Coverage To Support Worldwide Cure And Clinical Trials
- 5 Jun 2023
- Proviral Sequencing Driven Development Of Enhanced Ipdav2 With Global Hiv-1 Group M Coverage To Support Worldwide Cure And Clinical Trials
- National Institutes Of Health Nci
- Department Of Health And Human Services (Hhs)
- $2,000,000.00
- Department Of Health And Human Services (Hhs)
- 75N93023C00017
- Proviral Sequencing Driven Development Of Enhanced Ipdav2 With Global Hiv-1 Group M Coverage To Support Worldwide Cure And Clinical Trials
- 31 May 2023
- Proviral Sequencing Driven Development Of Enhanced Ipdav2 With Global Hiv-1 Group M Coverage To Support Worldwide Cure And Clinical Trials
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $2,000,000.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00015
- Eo14042: The Objective Of This Contract Is To Adapt The Ipda For The Measurement Of Latent Hiv-1 For Individuals With Hiv-1 Viral Genetic Subtype Crf-1_Ae.
- 2 Dec 2021
- Eo14042: The Objective Of This Contract Is To Adapt The Ipda For The Measurement Of Latent Hiv-1 For Individuals With Hiv-1 Viral Genetic Subtype Crf-1_Ae.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,975.00
- Department Of Health And Human Services (Hhs)
- 75N93020C00015
- The Objective Of This Contract Is To Adapt The Ipda For The Measurement Of Latent Hiv-1 For Individuals With Hiv-1 Viral Genetic Subtype Crf-1_Ae.
- 14 Feb 2022
- The Objective Of This Contract Is To Adapt The Ipda For The Measurement Of Latent Hiv-1 For Individuals With Hiv-1 Viral Genetic Subtype Crf-1_Ae.
- National Institutes Of Health Niaid
- Department Of Health And Human Services (Hhs)
- $299,975.00
- Department Of Health And Human Services (Hhs)